–
Israeli WideMed’s Morpheus Ox
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
–
Management team from Chinese Dehaier Medical Systems Ltd. (Nasdaq:DHRM) are visiting Israel, for four days, to meet with high-tech medical companies and pursue further discussions with its long-term partner, WideMed Ltd., to broaden cooperation opportunities.
Dehaier provides all-in-one solutions for the diagnosis, evaluation and treatment of obstructive sleep apnea (“OSA”). Based on support from WideMed, Dehaier has developed a new watch-sized device, which can be integrated into WideMed’s Morpheus Ox platform. By collecting and recording physiological data from patients who wear the watch-sized device at home, the advanced automatic sleep scoring software generates an accurate and reliable sleep study diagnosis, including Apnea Hypopnea Index (“AHI”), sleep/wake time, and Cheyne-Stokes breathing patterns.
The new system manages a cost-effective sleep services operation, including patient electronic medical records, cardiac and sleep diagnostics outcomes and complete workflow management. The web-based automatic scoring and data management facilitates operational efficiency and maximizes growth potential by giving users valuable and timely clinical information to improve patient treatment.
Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical, commented in a press reales , “Dehaier is focusing on research and development, SFDA registration and marketing activities of Efficient Sleep Diagnosis System. We deeply believe that the System has great market demand and development potential. By visiting WideMed and discussing further opportunities with them, we hope to reach a long-term agreement and deepen our cooperation. In addition, we believe that other Israeli high-tech medical companies will benefit from learning about Dehaier’s innovative and revolutionary medical products.”
–
